Latest news

Latest news, scientific publications and events

News

Withings acquires Impeto Medical

Press release: Withings acquires Impeto Medical Impeto Medical is a French company created in 2005  specializing in the research, development, production and sales of innovative …

January 10, 2022
Events

SUDOSCAN at NEURODIAB 2021

SUDOSCAN at NEURODIAB 2021: Symposium and five oral communications Impeto Medical has been delighted to participate to NeuroDiab congress 2021, the 31st annual meeting of …

September 7, 2021
Events

Successful Webinar “Management of autonomic dysfunction” – July 2021

Successful Webinar: Management of autonomic dysfunction:challenges & role of sudomotor testing With our special guests, on July 2021;     On July the 16th Impeto Medical …

July 16, 2021

Promotional Communication. The medical devices SUDOSCAN & EZSCAN are regulated health products under the CE certification, Class IIa, according to the European Medical Device directive – SGS Belgium, notified body 1639. The test allows screening and monitoring of peripheral autonomic neuropathies. It can be performed in diabetic patients or in patients suffering from neurological diseases involving small fibers damage. As with any diagnostic test, its results must be interpreted in a global context including the clinic and other examinations performed. Please read the user manual instructions carefully. Contact our office for more information. Last update: 2021/01/12

To receive our latest scientific news:

Website dedicated
to health professionals

I am a health professional

Scroll to Top